Content provided in partnership with

Technology Industry

Closure's Liquiderm Approved By Fda

BT Catalyst, Feb, 2001

Closure Medical Corp. (Nasdaq: CLSR) of Raleigh has received U.S. Food and Drug Administration (FDA) approval to market its Liquiderm[TM] liquid adhesive bandage.

Liquiderm[TM] adhesive is the first and only cyanoacrylate medical device approved by the FDA for the over-the counter (OTC) adhesive bandage market.

Liquiderm[TM] adhesive uses the same proprietary technology as Closure's Dermabond[R] topical skin adhesive, used in hospitals as an alternative for closing incisions and lacerations.

"The approval of Liquiderm[TM] adhesive brings the Dermabond[R] adhesive technology from the hospital into the home medicine cabinet," said Robert V. Toni, Closure's president and CEO.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

Closure is negotiating with a top-tier marketing partner for rights to the OTC wound-care platform.

Technology Industry

Closure's Liquiderm Approved By Fda

BT Catalyst, Feb, 2001

Find Research Guides for:

Find Featured Titles for: News

Most Popular Articles in Technology

Most Popular Publications in Technology